Molecular Oncology in Breast Cancer
In the present period, sub-atomic oncology has cleared its way in the exhaustive cancer care and is assuming a critical part, particularly in the disclosure of novel cell, focuses to misuse for novel focused on medications, new biomarkers distinguishing proof for early malignancy location, and to give a superior characterization of tumors for guess and treatment choice. The sub-atomic premise of breast carcinogenesis including hereditary and epigenetic occasions that outcome in the changed articulation of various qualities is yet not completely comprehended and still should be deciphered more, which mirrors the unpredictability of the sub-atomic modifications that portray tumor cells.
The majority of the breast malignancy genome is specifically subdued; around, 3-5% of qualities are dynamic in a specific tumor cell that is administered by the direction of quality articulation, for the most part at the level of translation. Cell bother (change) causes changes in quality articulation that outcome in the declaration of many quality items and the concealment of others. Consequently, sub-atomic heterogeneity is created that describes a tumor of various histology and adds to the changeability in result and reaction to treatment. Further, huge changeability additionally exists for tumors of a particular histologic write. Till as of late, in breast disease administration, clinical choices, visualizations, and expectations were constructed exclusively upon histopathologic investigation, or one or little quantities of qualities or their appearances (proteins) in the tumor tissue, yet this approach has been deficient and neglected to create exact conclusions. There has been a rise of the new worldview called "Genomic Paradigm," a move from the seniority "Clinico-Pathological Paradigm"
- Effects of proton radiation on foetus
- Pathological anatomy of early stage breast cancer
- Physics of accelerated partial breast irradiation
- Brachytherapy technique
- Bio engineering
Related Conference of Molecular Oncology in Breast Cancer
36th Conference on Preventive Oncology and Diagnostic Cancer
Molecular Oncology in Breast Cancer Conference Speakers
Recommended Sessions
- Cancer Therapeutics
- Breast and Cervical Cancer Screening
- Breast Cancer Biology
- Breast Reconstruction (Onco-plastic Surgery)
- Breastfeeding and Breast Cancer
- Cancer Biomarkers
- Cancer Epigenomics: Beyond Genomics
- Cancer Genomics
- Cancer Vaccination
- Cervical Cancer Biology
- Chemotherapy and Cancer
- Complementary and Alternative Medicine for cancer
- Gynaecologic Oncology
- HPV and Pregnancy
- Immunological Approaches to Cancer Therapy
- Male Breast Cancer
- Molecular Oncology in Breast Cancer
- Nanotechnology / Nano-medicines in Cancer Treatment
- Women’s Health and Contraception
Related Journals
Are you interested in
- AI Algorithms in breast Cancer - Cancer Biology 2023 (Hungary)
- Benign Breast Lesions: Diagnosis, Management, and Surveillance - Breast Pathology 2024 (Italy)
- Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice - Breast Pathology 2024 (Italy)
- Breast Cancer - Clinical Trails: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer during pregnancy: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer Radiation Therapy: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer Surgery: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer Therapies: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer treatment: - Breast Cancer Summit 2024 (Italy)
- Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Breast Imaging: Innovations in Radiology and Pathology Correlation - Breast Pathology 2024 (Italy)
- Breast Pathology in Pregnancy and Lactation: Challenges and Considerations - Breast Pathology 2024 (Italy)
- Cancer Biology - Cancer Biology 2023 (Hungary)
- Cancer Case reports - Euro Cancer 2023 (France)
- Cancer Cell Biology & Genetics - Euro Cancer 2023 (France)
- Cancer Pharmaceutics - Cancer Biology 2023 (Hungary)
- Cancer Prevention & Research - Euro Cancer 2023 (France)
- Cancer Science - Euro Cancer 2023 (France)
- Cancer Science - Cancer Biology 2023 (Hungary)
- Cancer Therapy - Euro Cancer 2023 (France)
- Chemotherapy for Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Clinical Oncology - Euro Cancer 2023 (France)
- Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ - Breast Pathology 2024 (Italy)
- Emerging Technologies in Breast Pathology: Digital Pathology, AI, and Machine Learning - Breast Pathology 2024 (Italy)
- Gynecology, Infectious Diseases and Oncology - Cancer Biology 2023 (Hungary)
- Hormonal Therapy - Cancer Biology 2023 (Hungary)
- Immunohistochemistry and Biomarkers in Breast Pathology - Breast Pathology 2024 (Italy)
- Immunotherapy and Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances - Breast Pathology 2024 (Italy)
- Innovations of Cancer - Cancer Biology 2023 (Hungary)
- Leukemia - Cancer Biology 2023 (Hungary)
- Male Breast Cancer Research: - Breast Cancer Summit 2024 (Italy)
- Mammography: - Breast Cancer Summit 2024 (Italy)
- Mastectomy: - Breast Cancer Summit 2024 (Italy)
- Metabolites in Cancer - Cancer Biology 2023 (Hungary)
- Metastatic Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Metastatic Breast Cancer: Pathological Insights and Treatment Approaches - Breast Pathology 2024 (Italy)
- Molecular Pathology: Unraveling Breast Cancer Subtypes - Breast Pathology 2024 (Italy)
- Multidisciplinary Approach to Breast Pathology: Collaboration between Pathologists, Radiologists, Surgeons, and Oncologists - Breast Pathology 2024 (Italy)
- Neonatal and Pediatric Oncology - Cancer Biology 2023 (Hungary)
- Oncology Nursing and Care - Euro Cancer 2023 (France)
- Oncology Nursing and Care - Cancer Biology 2023 (Hungary)
- Oral and Oropharyngeal Cancer - Cancer Biology 2023 (Hungary)
- Organ-Defined Cancers - Euro Cancer 2023 (France)
- Pathological Assessment of Breast Core Biopsies: Pitfalls and Best Practices - Breast Pathology 2024 (Italy)
- Pathological Assessment of Breast Reconstruction: Challenges and Surgical Considerations - Breast Pathology 2024 (Italy)
- Pathology in Cancer - Cancer Biology 2023 (Hungary)
- Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies - Breast Pathology 2024 (Italy)
- Precision Medicine in Breast Pathology: Integrating Genomics and Targeted Therapies - Breast Pathology 2024 (Italy)
- Prevention of Breast cancer: - Breast Cancer Summit 2024 (Italy)
- Quality of Life & Supportive Care - Cancer Biology 2023 (Hungary)
- Radiation Oncology - Euro Cancer 2023 (France)
- Radiation Therapy - Cancer Biology 2023 (Hungary)
- Radiation Therapy - Euro Cancer 2023 (France)
- Reconstruction of Breast Cancer: - Breast Cancer Summit 2024 (Italy)
- Regenerative Medicine - Cancer Biology 2023 (Hungary)
- Surgical Oncology - Cancer Biology 2023 (Hungary)
- Tumor Microenvironment - Cancer Biology 2023 (Hungary)
- Vaccines involvement in Cancer - Cancer Biology 2023 (Hungary)